Literature DB >> 33960315

How to define 30-day mortality?

Ali Rıza Akyüz1, Levent Korkmaz1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33960315      PMCID： PMC8114634          DOI： 10.5152/AnatolJCardiol.2021.60026

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN： 2149-2263            Impact factor:   1.475


× No keyword cloud information.
  6 in total

1.  Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies.

Authors:  Philippe Généreux; Stuart J Head; Nicolas M Van Mieghem; Susheel Kodali; Ajay J Kirtane; Ke Xu; Craig Smith; Patrick W Serruys; A Pieter Kappetein; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2012-04-11       Impact factor: 24.094

2.  Patients at Intermediate Surgical Risk Undergoing Isolated Interventional or Surgical Aortic Valve Implantation for Severe Symptomatic Aortic Valve Stenosis.

Authors:  Nicolas Werner; Ralf Zahn; Andreas Beckmann; Timm Bauer; Sabine Bleiziffer; Christian W Hamm; Raffi Berkeredjian; Alexander Berkowitsch; Friedrich W Mohr; Sandra Landwehr; Hugo A Katus; Wolfgang Harringer; Stephan Ensminger; Christian Frerker; Helge Möllmann; Thomas Walther; Steffen Schneider; Rüdiger Lange
Journal:  Circulation       Date:  2018-12-04       Impact factor: 29.690

3.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

Authors:  A Pieter Kappetein; Stuart J Head; Philippe Généreux; Nicolo Piazza; Nicolas M van Mieghem; Eugene H Blackstone; Thomas G Brott; David J Cohen; Donald E Cutlip; Gerrit-Anne van Es; Rebecca T Hahn; Ajay J Kirtane; Mitchell W Krucoff; Susheel Kodali; Michael J Mack; Roxana Mehran; Josep Rodés-Cabau; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys; Martin B Leon
Journal:  Eur Heart J       Date:  2012-10       Impact factor: 29.983

4.  Short-Term Outcomes of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Kidney Transplant Recipients (from the US Nationwide Representative Study).

Authors:  Omar M Abdelfattah; Anas M Saad; Abdelrahman Abushouk; Mohamed Hassanein; Toshiaki Isogai; Mohamed M Gad; Keerat Rai Ahuja; James Yun; Amar Krishnaswamy; Samir Kapadia
Journal:  Am J Cardiol       Date:  2020-12-29       Impact factor: 2.778

5.  Procedural Outcome and Midterm Survival of Lower Risk Transfemoral Transcatheter Aortic Valve Implantation Patients Treated With the SAPIEN XT or SAPIEN 3 Device.

Authors:  Jeroen Vendrik; Floortje van Kesteren; Martijn S van Mourik; Jan J Piek; Jan G Tijssen; Jose P S Henriques; Joanna J Wykrzykowska; Rob J de Winter; Antoine H G Driessen; Abdullah Kaya; M Marije Vis; Karel T Koch; Jan Baan
Journal:  Am J Cardiol       Date:  2018-01-11       Impact factor: 2.778

6.  Evaluation of procedural and clinical outcomes of transcatheter aortic valve implantation: A single-center experience.

Authors:  Bilge Duran Karaduman; Hüseyin Ayhan; Telat Keleş; Engin Bozkurt
Journal:  Anatol J Cardiol       Date:  2020-04       Impact factor: 1.475
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.